Susquehanna International Group
VRTX icon

Susquehanna International Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Susquehanna International Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$251M Buy
561,100
+76,300
+16% +$35.6M 0.03% 438
2025
Q4 		$220M Buy
484,800
+138,700
+40% +$59.8M 0.03% 502
2025
Q3 		$136M Sell
346,100
-59,400
-15% -$24.8M 0.02% 713
2025
Q2 		$181M Buy
405,500
+89,400
+28% +$41.2M 0.03% 484
2025
Q1 		$153M Sell
316,100
-114,700
-27% -$53.5M 0.03% 477
2024
Q4 		$173M Buy
430,800
+153,500
+55% +$71.2M 0.03% 473
2024
Q3 		$129M Buy
277,300
+5,900
+2% +$2.83M 0.02% 542
2024
Q2 		$127M Sell
271,400
-96,300
-26% -$41.8M 0.02% 508
2024
Q1 		$154M Sell
367,700
-111,400
-23% -$47.1M 0.03% 492
2023
Q4 		$195M Buy
479,100
+112,800
+31% +$41.7M 0.04% 402
2023
Q3 		$127M Sell
366,300
-10,200
-3% -$3.57M 0.03% 507
2023
Q2 		$132M Buy
376,500
+125,100
+50% +$42.2M 0.03% 485
2023
Q1 		$79.2M Sell
251,400
-18,200
-7% -$5.46M 0.02% 695
2022
Q4 		$77.9M Sell
269,600
-64,300
-19% -$19.6M 0.02% 661
2022
Q3 		$96.7M Sell
333,900
-55,500
-14% -$16M 0.03% 508
2022
Q2 		$110M Sell
389,400
-378,600
-49% -$101M 0.03% 493
2022
Q1 		$200M Buy
768,000
+268,100
+54% +$63.6M 0.03% 398
2021
Q4 		$110M Sell
499,900
-336,700
-40% -$65.5M 0.02% 680
2021
Q3 		$152M Sell
836,600
-86,400
-9% -$16.9M 0.02% 626
2021
Q2 		$186M Buy
923,000
+62,100
+7% +$13M 0.03% 534
2021
Q1 		$185M Buy
860,900
+481,400
+127% +$106M 0.03% 479
2020
Q4 		$89.7M Buy
379,500
+177,500
+88% +$40.7M 0.01% 707
2020
Q3 		$55M Sell
202,000
-25,800
-11% -$7.12M 0.01% 821
2020
Q2 		$66.1M Sell
227,800
-48,100
-17% -$13M 0.02% 682
2020
Q1 		$65.7M Buy
275,900
+104,800
+61% +$24M 0.02% 546
2019
Q4 		$37.5M Sell
171,100
-55,200
-24% -$11.2M 0.01% 980
2019
Q3 		$38.3M Sell
226,300
-10,200
-4% -$1.8M 0.01% 891
2019
Q2 		$43.4M Buy
236,500
+35,200
+17% +$6.15M 0.02% 773
2019
Q1 		$37M Sell
201,300
-727,700
-78% -$134M 0.02% 789
2018
Q4 		$154M Buy
929,000
+166,200
+22% +$28.8M 0.06% 269
2018
Q3 		$147M Buy
762,800
+156,900
+26% +$27.9M 0.05% 326
2018
Q2 		$103M Buy
605,900
+287,200
+90% +$44.5M 0.04% 409
2018
Q1 		$51.9M Buy
318,700
+18,600
+6% +$3.04M 0.02% 645
2017
Q4 		$45M Sell
300,100
-123,800
-29% -$18.3M 0.02% 743
2017
Q3 		$64.5M Sell
423,900
-106,000
-20% -$16M 0.02% 536
2017
Q2 		$68.3M Sell
529,900
-87,700
-14% -$10.6M 0.03% 476
2017
Q1 		$67.5M Buy
617,600
+265,700
+76% +$23.4M 0.03% 445
2016
Q4 		$25.9M Buy
351,900
+100,800
+40% +$8.2M 0.01% 870
2016
Q3 		$21.9M Buy
251,100
+24,400
+11% +$2.31M 0.01% 954
2016
Q2 		$19.5M Sell
226,700
-57,200
-20% -$4.94M 0.01% 996
2016
Q1 		$22.6M Sell
283,900
-39,600
-12% -$3.58M 0.01% 921
2015
Q4 		$40.7M Sell
323,500
-30,600
-9% -$3.69M 0.02% 710
2015
Q3 		$36.9M Sell
354,100
-225,500
-39% -$29M 0.02% 802
2015
Q2 		$71.6M Buy
579,600
+156,900
+37% +$19.8M 0.03% 520
2015
Q1 		$49.9M Sell
422,700
-1,329,800
-76% -$159M 0.02% 631
2014
Q4 		$208M Sell
1,752,500
-221,300
-11% -$24.9M 0.08% 218
2014
Q3 		$222M Sell
1,973,800
-917,700
-32% -$87.4M 0.09% 195
2014
Q2 		$274M Buy
2,891,500
+1,659,600
+135% +$116M 0.12% 131
2014
Q1 		$87.1M Sell
1,231,900
-113,200
-8% -$8.97M 0.04% 390
2013
Q4 		$99.9M Buy
1,345,100
+274,300
+26% +$19.1M 0.05% 352
2013
Q3 		$81.2M Sell
1,070,800
-238,400
-18% -$19M 0.04% 381
2013
Q2 		$105M Buy
+1,309,200
New +$96.4M 0.06% 256

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group's VRTX Position: Q1 2026 in Review

Susquehanna International Group reduced its Vertex Pharmaceuticals (VRTX) stake by 76% in Q1 2026, selling an estimated $29.8M and leaving 20,221 shares worth $9.03M. The position accounts for ﹤0.01% of the portfolio, ranked #3275.

Susquehanna International Group first reported a position in VRTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $107M in Q1 2021. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Susquehanna International Group held 20,221 shares of Vertex Pharmaceuticals worth $9.03M as of Q1 2026.
  • Susquehanna International Group sold 63,875 Vertex Pharmaceuticals shares in Q1 2026, an estimated $29.8M.
  • Vertex Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3275 holding.
  • Susquehanna International Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's Vertex Pharmaceuticals position peaked at $107M in Q1 2021.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.